Global Genetic Testing for Cancer Risk Market Growth (Status and Outlook) 2026-2032
The global Genetic Testing for Cancer Risk market size is predicted to grow from US$ 5738 million in 2025 to US$ 13100 million in 2032; it is expected to grow at a CAGR of 12.8% from 2026 to 2032.
Cancer risk genetic testing looks for changes in someone"s genes. Genetic changes can cause some cancers. Some cancers can run in families.
The demand for genetic testing for cancer risk has been increasing in recent years due to the growing understanding of the role of genetics in cancer development and the desire for personalized healthcare. Genetic tests can provide valuable information for individuals and healthcare professionals, allowing for early detection, prevention, and personalized treatment strategies.
LPI (LP Information)' newest research report, the “Genetic Testing for Cancer Risk Industry Forecast” looks at past sales and reviews total world Genetic Testing for Cancer Risk sales in 2025, providing a comprehensive analysis by region and market sector of projected Genetic Testing for Cancer Risk sales for 2026 through 2032. With Genetic Testing for Cancer Risk sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genetic Testing for Cancer Risk industry.
This Insight Report provides a comprehensive analysis of the global Genetic Testing for Cancer Risk landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Genetic Testing for Cancer Risk portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Genetic Testing for Cancer Risk market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genetic Testing for Cancer Risk and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genetic Testing for Cancer Risk.
This report presents a comprehensive overview, market shares, and growth opportunities of Genetic Testing for Cancer Risk market by product type, application, key players and key regions and countries.
Cancer risk genetic testing looks for changes in someone"s genes. Genetic changes can cause some cancers. Some cancers can run in families.
The demand for genetic testing for cancer risk has been increasing in recent years due to the growing understanding of the role of genetics in cancer development and the desire for personalized healthcare. Genetic tests can provide valuable information for individuals and healthcare professionals, allowing for early detection, prevention, and personalized treatment strategies.
LPI (LP Information)' newest research report, the “Genetic Testing for Cancer Risk Industry Forecast” looks at past sales and reviews total world Genetic Testing for Cancer Risk sales in 2025, providing a comprehensive analysis by region and market sector of projected Genetic Testing for Cancer Risk sales for 2026 through 2032. With Genetic Testing for Cancer Risk sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genetic Testing for Cancer Risk industry.
This Insight Report provides a comprehensive analysis of the global Genetic Testing for Cancer Risk landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Genetic Testing for Cancer Risk portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Genetic Testing for Cancer Risk market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genetic Testing for Cancer Risk and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genetic Testing for Cancer Risk.
This report presents a comprehensive overview, market shares, and growth opportunities of Genetic Testing for Cancer Risk market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Breast Cancer Risk Genetic Testing
- Stomach Cancer Risk Gene Testing
- Rectal Cancer Risk Genetic Testing
- Others
Segmentation by Application:
- Hospital
- Clinic
- Laboratory
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Myriad Genetics, Inc.
- Invitae Corporation
- Illumina, Inc.
- Natera, Inc.
- Laboratory Corporation of America Holdings
- F. Hoffmann-La Roche Ltd
- Quest Diagnostics Incorporated
- CooperSurgical, Inc.
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc.
- Twist Bioscience
- Sophia Genetics
- Fulgent Genetic, Inc.
- Medgenome
- CENTOGENE
- CeGaT
- LifeLabs Genetics
- Ambry Genetics
- BGI
- SOFIVA GENOMICS
- Yikon Medical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Genetic Testing for Cancer Risk Market Size (2021-2032)
2.1.2 Genetic Testing for Cancer Risk Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Genetic Testing for Cancer Risk by Country/Region (2021, 2025 & 2032)
2.2 Genetic Testing for Cancer Risk Segment by Type
2.2.1 Breast Cancer Risk Genetic Testing
2.2.2 Stomach Cancer Risk Gene Testing
2.2.3 Rectal Cancer Risk Genetic Testing
2.2.4 Others
2.2.5 Genetic Testing for Cancer Risk Market Size by Type
2.2.5.1 Genetic Testing for Cancer Risk Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Genetic Testing for Cancer Risk Market Size Market Share by Type (2021-2026)
2.3 Genetic Testing for Cancer Risk Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Laboratory
2.3.4 Genetic Testing for Cancer Risk Market Size by Application
2.3.4.1 Genetic Testing for Cancer Risk Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Genetic Testing for Cancer Risk Market Size Market Share by Application (2021-2026)
3 GENETIC TESTING FOR CANCER RISK MARKET SIZE BY PLAYER
3.1 Genetic Testing for Cancer Risk Market Size Market Share by Player
3.1.1 Global Genetic Testing for Cancer Risk Revenue by Player (2021-2026)
3.1.2 Global Genetic Testing for Cancer Risk Revenue Market Share by Player (2021-2026)
3.2 Global Genetic Testing for Cancer Risk Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENETIC TESTING FOR CANCER RISK BY REGION
4.1 Genetic Testing for Cancer Risk Market Size by Region (2021-2026)
4.2 Global Genetic Testing for Cancer Risk Annual Revenue by Country/Region (2021-2026)
4.3 Americas Genetic Testing for Cancer Risk Market Size Growth (2021-2026)
4.4 APAC Genetic Testing for Cancer Risk Market Size Growth (2021-2026)
4.5 Europe Genetic Testing for Cancer Risk Market Size Growth (2021-2026)
4.6 Middle East & Africa Genetic Testing for Cancer Risk Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Genetic Testing for Cancer Risk Market Size by Country (2021-2026)
5.2 Americas Genetic Testing for Cancer Risk Market Size by Type (2021-2026)
5.3 Americas Genetic Testing for Cancer Risk Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Genetic Testing for Cancer Risk Market Size by Region (2021-2026)
6.2 APAC Genetic Testing for Cancer Risk Market Size by Type (2021-2026)
6.3 APAC Genetic Testing for Cancer Risk Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Genetic Testing for Cancer Risk Market Size by Country (2021-2026)
7.2 Europe Genetic Testing for Cancer Risk Market Size by Type (2021-2026)
7.3 Europe Genetic Testing for Cancer Risk Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Genetic Testing for Cancer Risk by Region (2021-2026)
8.2 Middle East & Africa Genetic Testing for Cancer Risk Market Size by Type (2021-2026)
8.3 Middle East & Africa Genetic Testing for Cancer Risk Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENETIC TESTING FOR CANCER RISK MARKET FORECAST
10.1 Global Genetic Testing for Cancer Risk Forecast by Region (2027-2032)
10.1.1 Global Genetic Testing for Cancer Risk Forecast by Region (2027-2032)
10.1.2 Americas Genetic Testing for Cancer Risk Forecast
10.1.3 APAC Genetic Testing for Cancer Risk Forecast
10.1.4 Europe Genetic Testing for Cancer Risk Forecast
10.1.5 Middle East & Africa Genetic Testing for Cancer Risk Forecast
10.2 Americas Genetic Testing for Cancer Risk Forecast by Country (2027-2032)
10.2.1 United States Market Genetic Testing for Cancer Risk Forecast
10.2.2 Canada Market Genetic Testing for Cancer Risk Forecast
10.2.3 Mexico Market Genetic Testing for Cancer Risk Forecast
10.2.4 Brazil Market Genetic Testing for Cancer Risk Forecast
10.3 APAC Genetic Testing for Cancer Risk Forecast by Region (2027-2032)
10.3.1 China Genetic Testing for Cancer Risk Market Forecast
10.3.2 Japan Market Genetic Testing for Cancer Risk Forecast
10.3.3 Korea Market Genetic Testing for Cancer Risk Forecast
10.3.4 Southeast Asia Market Genetic Testing for Cancer Risk Forecast
10.3.5 India Market Genetic Testing for Cancer Risk Forecast
10.3.6 Australia Market Genetic Testing for Cancer Risk Forecast
10.4 Europe Genetic Testing for Cancer Risk Forecast by Country (2027-2032)
10.4.1 Germany Market Genetic Testing for Cancer Risk Forecast
10.4.2 France Market Genetic Testing for Cancer Risk Forecast
10.4.3 UK Market Genetic Testing for Cancer Risk Forecast
10.4.4 Italy Market Genetic Testing for Cancer Risk Forecast
10.4.5 Russia Market Genetic Testing for Cancer Risk Forecast
10.5 Middle East & Africa Genetic Testing for Cancer Risk Forecast by Region (2027-2032)
10.5.1 Egypt Market Genetic Testing for Cancer Risk Forecast
10.5.2 South Africa Market Genetic Testing for Cancer Risk Forecast
10.5.3 Israel Market Genetic Testing for Cancer Risk Forecast
10.5.4 Turkey Market Genetic Testing for Cancer Risk Forecast
10.6 Global Genetic Testing for Cancer Risk Forecast by Type (2027-2032)
10.7 Global Genetic Testing for Cancer Risk Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Genetic Testing for Cancer Risk Forecast
11 KEY PLAYERS ANALYSIS
11.1 Myriad Genetics, Inc.
11.1.1 Myriad Genetics, Inc. Company Information
11.1.2 Myriad Genetics, Inc. Genetic Testing for Cancer Risk Product Offered
11.1.3 Myriad Genetics, Inc. Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Myriad Genetics, Inc. Main Business Overview
11.1.5 Myriad Genetics, Inc. Latest Developments
11.2 Invitae Corporation
11.2.1 Invitae Corporation Company Information
11.2.2 Invitae Corporation Genetic Testing for Cancer Risk Product Offered
11.2.3 Invitae Corporation Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Invitae Corporation Main Business Overview
11.2.5 Invitae Corporation Latest Developments
11.3 Illumina, Inc.
11.3.1 Illumina, Inc. Company Information
11.3.2 Illumina, Inc. Genetic Testing for Cancer Risk Product Offered
11.3.3 Illumina, Inc. Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Illumina, Inc. Main Business Overview
11.3.5 Illumina, Inc. Latest Developments
11.4 Natera, Inc.
11.4.1 Natera, Inc. Company Information
11.4.2 Natera, Inc. Genetic Testing for Cancer Risk Product Offered
11.4.3 Natera, Inc. Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Natera, Inc. Main Business Overview
11.4.5 Natera, Inc. Latest Developments
11.5 Laboratory Corporation of America Holdings
11.5.1 Laboratory Corporation of America Holdings Company Information
11.5.2 Laboratory Corporation of America Holdings Genetic Testing for Cancer Risk Product Offered
11.5.3 Laboratory Corporation of America Holdings Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Laboratory Corporation of America Holdings Main Business Overview
11.5.5 Laboratory Corporation of America Holdings Latest Developments
11.6 F. Hoffmann-La Roche Ltd
11.6.1 F. Hoffmann-La Roche Ltd Company Information
11.6.2 F. Hoffmann-La Roche Ltd Genetic Testing for Cancer Risk Product Offered
11.6.3 F. Hoffmann-La Roche Ltd Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 F. Hoffmann-La Roche Ltd Main Business Overview
11.6.5 F. Hoffmann-La Roche Ltd Latest Developments
11.7 Quest Diagnostics Incorporated
11.7.1 Quest Diagnostics Incorporated Company Information
11.7.2 Quest Diagnostics Incorporated Genetic Testing for Cancer Risk Product Offered
11.7.3 Quest Diagnostics Incorporated Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Quest Diagnostics Incorporated Main Business Overview
11.7.5 Quest Diagnostics Incorporated Latest Developments
11.8 CooperSurgical, Inc.
11.8.1 CooperSurgical, Inc. Company Information
11.8.2 CooperSurgical, Inc. Genetic Testing for Cancer Risk Product Offered
11.8.3 CooperSurgical, Inc. Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 CooperSurgical, Inc. Main Business Overview
11.8.5 CooperSurgical, Inc. Latest Developments
11.9 Agilent Technologies, Inc.
11.9.1 Agilent Technologies, Inc. Company Information
11.9.2 Agilent Technologies, Inc. Genetic Testing for Cancer Risk Product Offered
11.9.3 Agilent Technologies, Inc. Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Agilent Technologies, Inc. Main Business Overview
11.9.5 Agilent Technologies, Inc. Latest Developments
11.10 Thermo Fisher Scientific, Inc.
11.10.1 Thermo Fisher Scientific, Inc. Company Information
11.10.2 Thermo Fisher Scientific, Inc. Genetic Testing for Cancer Risk Product Offered
11.10.3 Thermo Fisher Scientific, Inc. Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Thermo Fisher Scientific, Inc. Main Business Overview
11.10.5 Thermo Fisher Scientific, Inc. Latest Developments
11.11 Twist Bioscience
11.11.1 Twist Bioscience Company Information
11.11.2 Twist Bioscience Genetic Testing for Cancer Risk Product Offered
11.11.3 Twist Bioscience Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Twist Bioscience Main Business Overview
11.11.5 Twist Bioscience Latest Developments
11.12 Sophia Genetics
11.12.1 Sophia Genetics Company Information
11.12.2 Sophia Genetics Genetic Testing for Cancer Risk Product Offered
11.12.3 Sophia Genetics Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Sophia Genetics Main Business Overview
11.12.5 Sophia Genetics Latest Developments
11.13 Fulgent Genetic, Inc.
11.13.1 Fulgent Genetic, Inc. Company Information
11.13.2 Fulgent Genetic, Inc. Genetic Testing for Cancer Risk Product Offered
11.13.3 Fulgent Genetic, Inc. Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Fulgent Genetic, Inc. Main Business Overview
11.13.5 Fulgent Genetic, Inc. Latest Developments
11.14 Medgenome
11.14.1 Medgenome Company Information
11.14.2 Medgenome Genetic Testing for Cancer Risk Product Offered
11.14.3 Medgenome Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Medgenome Main Business Overview
11.14.5 Medgenome Latest Developments
11.15 CENTOGENE
11.15.1 CENTOGENE Company Information
11.15.2 CENTOGENE Genetic Testing for Cancer Risk Product Offered
11.15.3 CENTOGENE Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 CENTOGENE Main Business Overview
11.15.5 CENTOGENE Latest Developments
11.16 CeGaT
11.16.1 CeGaT Company Information
11.16.2 CeGaT Genetic Testing for Cancer Risk Product Offered
11.16.3 CeGaT Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 CeGaT Main Business Overview
11.16.5 CeGaT Latest Developments
11.17 LifeLabs Genetics
11.17.1 LifeLabs Genetics Company Information
11.17.2 LifeLabs Genetics Genetic Testing for Cancer Risk Product Offered
11.17.3 LifeLabs Genetics Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 LifeLabs Genetics Main Business Overview
11.17.5 LifeLabs Genetics Latest Developments
11.18 Ambry Genetics
11.18.1 Ambry Genetics Company Information
11.18.2 Ambry Genetics Genetic Testing for Cancer Risk Product Offered
11.18.3 Ambry Genetics Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Ambry Genetics Main Business Overview
11.18.5 Ambry Genetics Latest Developments
11.19 BGI
11.19.1 BGI Company Information
11.19.2 BGI Genetic Testing for Cancer Risk Product Offered
11.19.3 BGI Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 BGI Main Business Overview
11.19.5 BGI Latest Developments
11.20 SOFIVA GENOMICS
11.20.1 SOFIVA GENOMICS Company Information
11.20.2 SOFIVA GENOMICS Genetic Testing for Cancer Risk Product Offered
11.20.3 SOFIVA GENOMICS Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 SOFIVA GENOMICS Main Business Overview
11.20.5 SOFIVA GENOMICS Latest Developments
11.21 Yikon Medical
11.21.1 Yikon Medical Company Information
11.21.2 Yikon Medical Genetic Testing for Cancer Risk Product Offered
11.21.3 Yikon Medical Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Yikon Medical Main Business Overview
11.21.5 Yikon Medical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Genetic Testing for Cancer Risk Market Size (2021-2032)
2.1.2 Genetic Testing for Cancer Risk Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Genetic Testing for Cancer Risk by Country/Region (2021, 2025 & 2032)
2.2 Genetic Testing for Cancer Risk Segment by Type
2.2.1 Breast Cancer Risk Genetic Testing
2.2.2 Stomach Cancer Risk Gene Testing
2.2.3 Rectal Cancer Risk Genetic Testing
2.2.4 Others
2.2.5 Genetic Testing for Cancer Risk Market Size by Type
2.2.5.1 Genetic Testing for Cancer Risk Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Genetic Testing for Cancer Risk Market Size Market Share by Type (2021-2026)
2.3 Genetic Testing for Cancer Risk Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Laboratory
2.3.4 Genetic Testing for Cancer Risk Market Size by Application
2.3.4.1 Genetic Testing for Cancer Risk Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Genetic Testing for Cancer Risk Market Size Market Share by Application (2021-2026)
3 GENETIC TESTING FOR CANCER RISK MARKET SIZE BY PLAYER
3.1 Genetic Testing for Cancer Risk Market Size Market Share by Player
3.1.1 Global Genetic Testing for Cancer Risk Revenue by Player (2021-2026)
3.1.2 Global Genetic Testing for Cancer Risk Revenue Market Share by Player (2021-2026)
3.2 Global Genetic Testing for Cancer Risk Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENETIC TESTING FOR CANCER RISK BY REGION
4.1 Genetic Testing for Cancer Risk Market Size by Region (2021-2026)
4.2 Global Genetic Testing for Cancer Risk Annual Revenue by Country/Region (2021-2026)
4.3 Americas Genetic Testing for Cancer Risk Market Size Growth (2021-2026)
4.4 APAC Genetic Testing for Cancer Risk Market Size Growth (2021-2026)
4.5 Europe Genetic Testing for Cancer Risk Market Size Growth (2021-2026)
4.6 Middle East & Africa Genetic Testing for Cancer Risk Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Genetic Testing for Cancer Risk Market Size by Country (2021-2026)
5.2 Americas Genetic Testing for Cancer Risk Market Size by Type (2021-2026)
5.3 Americas Genetic Testing for Cancer Risk Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Genetic Testing for Cancer Risk Market Size by Region (2021-2026)
6.2 APAC Genetic Testing for Cancer Risk Market Size by Type (2021-2026)
6.3 APAC Genetic Testing for Cancer Risk Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Genetic Testing for Cancer Risk Market Size by Country (2021-2026)
7.2 Europe Genetic Testing for Cancer Risk Market Size by Type (2021-2026)
7.3 Europe Genetic Testing for Cancer Risk Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Genetic Testing for Cancer Risk by Region (2021-2026)
8.2 Middle East & Africa Genetic Testing for Cancer Risk Market Size by Type (2021-2026)
8.3 Middle East & Africa Genetic Testing for Cancer Risk Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENETIC TESTING FOR CANCER RISK MARKET FORECAST
10.1 Global Genetic Testing for Cancer Risk Forecast by Region (2027-2032)
10.1.1 Global Genetic Testing for Cancer Risk Forecast by Region (2027-2032)
10.1.2 Americas Genetic Testing for Cancer Risk Forecast
10.1.3 APAC Genetic Testing for Cancer Risk Forecast
10.1.4 Europe Genetic Testing for Cancer Risk Forecast
10.1.5 Middle East & Africa Genetic Testing for Cancer Risk Forecast
10.2 Americas Genetic Testing for Cancer Risk Forecast by Country (2027-2032)
10.2.1 United States Market Genetic Testing for Cancer Risk Forecast
10.2.2 Canada Market Genetic Testing for Cancer Risk Forecast
10.2.3 Mexico Market Genetic Testing for Cancer Risk Forecast
10.2.4 Brazil Market Genetic Testing for Cancer Risk Forecast
10.3 APAC Genetic Testing for Cancer Risk Forecast by Region (2027-2032)
10.3.1 China Genetic Testing for Cancer Risk Market Forecast
10.3.2 Japan Market Genetic Testing for Cancer Risk Forecast
10.3.3 Korea Market Genetic Testing for Cancer Risk Forecast
10.3.4 Southeast Asia Market Genetic Testing for Cancer Risk Forecast
10.3.5 India Market Genetic Testing for Cancer Risk Forecast
10.3.6 Australia Market Genetic Testing for Cancer Risk Forecast
10.4 Europe Genetic Testing for Cancer Risk Forecast by Country (2027-2032)
10.4.1 Germany Market Genetic Testing for Cancer Risk Forecast
10.4.2 France Market Genetic Testing for Cancer Risk Forecast
10.4.3 UK Market Genetic Testing for Cancer Risk Forecast
10.4.4 Italy Market Genetic Testing for Cancer Risk Forecast
10.4.5 Russia Market Genetic Testing for Cancer Risk Forecast
10.5 Middle East & Africa Genetic Testing for Cancer Risk Forecast by Region (2027-2032)
10.5.1 Egypt Market Genetic Testing for Cancer Risk Forecast
10.5.2 South Africa Market Genetic Testing for Cancer Risk Forecast
10.5.3 Israel Market Genetic Testing for Cancer Risk Forecast
10.5.4 Turkey Market Genetic Testing for Cancer Risk Forecast
10.6 Global Genetic Testing for Cancer Risk Forecast by Type (2027-2032)
10.7 Global Genetic Testing for Cancer Risk Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Genetic Testing for Cancer Risk Forecast
11 KEY PLAYERS ANALYSIS
11.1 Myriad Genetics, Inc.
11.1.1 Myriad Genetics, Inc. Company Information
11.1.2 Myriad Genetics, Inc. Genetic Testing for Cancer Risk Product Offered
11.1.3 Myriad Genetics, Inc. Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Myriad Genetics, Inc. Main Business Overview
11.1.5 Myriad Genetics, Inc. Latest Developments
11.2 Invitae Corporation
11.2.1 Invitae Corporation Company Information
11.2.2 Invitae Corporation Genetic Testing for Cancer Risk Product Offered
11.2.3 Invitae Corporation Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Invitae Corporation Main Business Overview
11.2.5 Invitae Corporation Latest Developments
11.3 Illumina, Inc.
11.3.1 Illumina, Inc. Company Information
11.3.2 Illumina, Inc. Genetic Testing for Cancer Risk Product Offered
11.3.3 Illumina, Inc. Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Illumina, Inc. Main Business Overview
11.3.5 Illumina, Inc. Latest Developments
11.4 Natera, Inc.
11.4.1 Natera, Inc. Company Information
11.4.2 Natera, Inc. Genetic Testing for Cancer Risk Product Offered
11.4.3 Natera, Inc. Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Natera, Inc. Main Business Overview
11.4.5 Natera, Inc. Latest Developments
11.5 Laboratory Corporation of America Holdings
11.5.1 Laboratory Corporation of America Holdings Company Information
11.5.2 Laboratory Corporation of America Holdings Genetic Testing for Cancer Risk Product Offered
11.5.3 Laboratory Corporation of America Holdings Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Laboratory Corporation of America Holdings Main Business Overview
11.5.5 Laboratory Corporation of America Holdings Latest Developments
11.6 F. Hoffmann-La Roche Ltd
11.6.1 F. Hoffmann-La Roche Ltd Company Information
11.6.2 F. Hoffmann-La Roche Ltd Genetic Testing for Cancer Risk Product Offered
11.6.3 F. Hoffmann-La Roche Ltd Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 F. Hoffmann-La Roche Ltd Main Business Overview
11.6.5 F. Hoffmann-La Roche Ltd Latest Developments
11.7 Quest Diagnostics Incorporated
11.7.1 Quest Diagnostics Incorporated Company Information
11.7.2 Quest Diagnostics Incorporated Genetic Testing for Cancer Risk Product Offered
11.7.3 Quest Diagnostics Incorporated Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Quest Diagnostics Incorporated Main Business Overview
11.7.5 Quest Diagnostics Incorporated Latest Developments
11.8 CooperSurgical, Inc.
11.8.1 CooperSurgical, Inc. Company Information
11.8.2 CooperSurgical, Inc. Genetic Testing for Cancer Risk Product Offered
11.8.3 CooperSurgical, Inc. Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 CooperSurgical, Inc. Main Business Overview
11.8.5 CooperSurgical, Inc. Latest Developments
11.9 Agilent Technologies, Inc.
11.9.1 Agilent Technologies, Inc. Company Information
11.9.2 Agilent Technologies, Inc. Genetic Testing for Cancer Risk Product Offered
11.9.3 Agilent Technologies, Inc. Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Agilent Technologies, Inc. Main Business Overview
11.9.5 Agilent Technologies, Inc. Latest Developments
11.10 Thermo Fisher Scientific, Inc.
11.10.1 Thermo Fisher Scientific, Inc. Company Information
11.10.2 Thermo Fisher Scientific, Inc. Genetic Testing for Cancer Risk Product Offered
11.10.3 Thermo Fisher Scientific, Inc. Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Thermo Fisher Scientific, Inc. Main Business Overview
11.10.5 Thermo Fisher Scientific, Inc. Latest Developments
11.11 Twist Bioscience
11.11.1 Twist Bioscience Company Information
11.11.2 Twist Bioscience Genetic Testing for Cancer Risk Product Offered
11.11.3 Twist Bioscience Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Twist Bioscience Main Business Overview
11.11.5 Twist Bioscience Latest Developments
11.12 Sophia Genetics
11.12.1 Sophia Genetics Company Information
11.12.2 Sophia Genetics Genetic Testing for Cancer Risk Product Offered
11.12.3 Sophia Genetics Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Sophia Genetics Main Business Overview
11.12.5 Sophia Genetics Latest Developments
11.13 Fulgent Genetic, Inc.
11.13.1 Fulgent Genetic, Inc. Company Information
11.13.2 Fulgent Genetic, Inc. Genetic Testing for Cancer Risk Product Offered
11.13.3 Fulgent Genetic, Inc. Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Fulgent Genetic, Inc. Main Business Overview
11.13.5 Fulgent Genetic, Inc. Latest Developments
11.14 Medgenome
11.14.1 Medgenome Company Information
11.14.2 Medgenome Genetic Testing for Cancer Risk Product Offered
11.14.3 Medgenome Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Medgenome Main Business Overview
11.14.5 Medgenome Latest Developments
11.15 CENTOGENE
11.15.1 CENTOGENE Company Information
11.15.2 CENTOGENE Genetic Testing for Cancer Risk Product Offered
11.15.3 CENTOGENE Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 CENTOGENE Main Business Overview
11.15.5 CENTOGENE Latest Developments
11.16 CeGaT
11.16.1 CeGaT Company Information
11.16.2 CeGaT Genetic Testing for Cancer Risk Product Offered
11.16.3 CeGaT Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 CeGaT Main Business Overview
11.16.5 CeGaT Latest Developments
11.17 LifeLabs Genetics
11.17.1 LifeLabs Genetics Company Information
11.17.2 LifeLabs Genetics Genetic Testing for Cancer Risk Product Offered
11.17.3 LifeLabs Genetics Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 LifeLabs Genetics Main Business Overview
11.17.5 LifeLabs Genetics Latest Developments
11.18 Ambry Genetics
11.18.1 Ambry Genetics Company Information
11.18.2 Ambry Genetics Genetic Testing for Cancer Risk Product Offered
11.18.3 Ambry Genetics Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Ambry Genetics Main Business Overview
11.18.5 Ambry Genetics Latest Developments
11.19 BGI
11.19.1 BGI Company Information
11.19.2 BGI Genetic Testing for Cancer Risk Product Offered
11.19.3 BGI Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 BGI Main Business Overview
11.19.5 BGI Latest Developments
11.20 SOFIVA GENOMICS
11.20.1 SOFIVA GENOMICS Company Information
11.20.2 SOFIVA GENOMICS Genetic Testing for Cancer Risk Product Offered
11.20.3 SOFIVA GENOMICS Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 SOFIVA GENOMICS Main Business Overview
11.20.5 SOFIVA GENOMICS Latest Developments
11.21 Yikon Medical
11.21.1 Yikon Medical Company Information
11.21.2 Yikon Medical Genetic Testing for Cancer Risk Product Offered
11.21.3 Yikon Medical Genetic Testing for Cancer Risk Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Yikon Medical Main Business Overview
11.21.5 Yikon Medical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Genetic Testing for Cancer Risk Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Genetic Testing for Cancer Risk Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Breast Cancer Risk Genetic Testing
Table 4. Major Players of Stomach Cancer Risk Gene Testing
Table 5. Major Players of Rectal Cancer Risk Genetic Testing
Table 6. Major Players of Others
Table 7. Genetic Testing for Cancer Risk Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Genetic Testing for Cancer Risk Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Genetic Testing for Cancer Risk Market Size Market Share by Type (2021-2026)
Table 10. Genetic Testing for Cancer Risk Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Genetic Testing for Cancer Risk Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Genetic Testing for Cancer Risk Market Size Market Share by Application (2021-2026)
Table 13. Global Genetic Testing for Cancer Risk Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Genetic Testing for Cancer Risk Revenue Market Share by Player (2021-2026)
Table 15. Genetic Testing for Cancer Risk Key Players Head office and Products Offered
Table 16. Genetic Testing for Cancer Risk Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Genetic Testing for Cancer Risk Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Genetic Testing for Cancer Risk Market Size Market Share by Region (2021-2026)
Table 21. Global Genetic Testing for Cancer Risk Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Genetic Testing for Cancer Risk Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Genetic Testing for Cancer Risk Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Genetic Testing for Cancer Risk Market Size Market Share by Country (2021-2026)
Table 25. Americas Genetic Testing for Cancer Risk Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Genetic Testing for Cancer Risk Market Size Market Share by Type (2021-2026)
Table 27. Americas Genetic Testing for Cancer Risk Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Genetic Testing for Cancer Risk Market Size Market Share by Application (2021-2026)
Table 29. APAC Genetic Testing for Cancer Risk Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Genetic Testing for Cancer Risk Market Size Market Share by Region (2021-2026)
Table 31. APAC Genetic Testing for Cancer Risk Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Genetic Testing for Cancer Risk Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Genetic Testing for Cancer Risk Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Genetic Testing for Cancer Risk Market Size Market Share by Country (2021-2026)
Table 35. Europe Genetic Testing for Cancer Risk Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Genetic Testing for Cancer Risk Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Genetic Testing for Cancer Risk Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Genetic Testing for Cancer Risk Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Genetic Testing for Cancer Risk Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Genetic Testing for Cancer Risk
Table 41. Key Market Challenges & Risks of Genetic Testing for Cancer Risk
Table 42. Key Industry Trends of Genetic Testing for Cancer Risk
Table 43. Global Genetic Testing for Cancer Risk Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Genetic Testing for Cancer Risk Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Genetic Testing for Cancer Risk Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Genetic Testing for Cancer Risk Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Myriad Genetics, Inc. Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 48. Myriad Genetics, Inc. Genetic Testing for Cancer Risk Product Offered
Table 49. Myriad Genetics, Inc. Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Myriad Genetics, Inc. Main Business
Table 51. Myriad Genetics, Inc. Latest Developments
Table 52. Invitae Corporation Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 53. Invitae Corporation Genetic Testing for Cancer Risk Product Offered
Table 54. Invitae Corporation Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Invitae Corporation Main Business
Table 56. Invitae Corporation Latest Developments
Table 57. Illumina, Inc. Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 58. Illumina, Inc. Genetic Testing for Cancer Risk Product Offered
Table 59. Illumina, Inc. Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Illumina, Inc. Main Business
Table 61. Illumina, Inc. Latest Developments
Table 62. Natera, Inc. Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 63. Natera, Inc. Genetic Testing for Cancer Risk Product Offered
Table 64. Natera, Inc. Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Natera, Inc. Main Business
Table 66. Natera, Inc. Latest Developments
Table 67. Laboratory Corporation of America Holdings Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 68. Laboratory Corporation of America Holdings Genetic Testing for Cancer Risk Product Offered
Table 69. Laboratory Corporation of America Holdings Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Laboratory Corporation of America Holdings Main Business
Table 71. Laboratory Corporation of America Holdings Latest Developments
Table 72. F. Hoffmann-La Roche Ltd Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 73. F. Hoffmann-La Roche Ltd Genetic Testing for Cancer Risk Product Offered
Table 74. F. Hoffmann-La Roche Ltd Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. F. Hoffmann-La Roche Ltd Main Business
Table 76. F. Hoffmann-La Roche Ltd Latest Developments
Table 77. Quest Diagnostics Incorporated Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 78. Quest Diagnostics Incorporated Genetic Testing for Cancer Risk Product Offered
Table 79. Quest Diagnostics Incorporated Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Quest Diagnostics Incorporated Main Business
Table 81. Quest Diagnostics Incorporated Latest Developments
Table 82. CooperSurgical, Inc. Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 83. CooperSurgical, Inc. Genetic Testing for Cancer Risk Product Offered
Table 84. CooperSurgical, Inc. Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. CooperSurgical, Inc. Main Business
Table 86. CooperSurgical, Inc. Latest Developments
Table 87. Agilent Technologies, Inc. Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 88. Agilent Technologies, Inc. Genetic Testing for Cancer Risk Product Offered
Table 89. Agilent Technologies, Inc. Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Agilent Technologies, Inc. Main Business
Table 91. Agilent Technologies, Inc. Latest Developments
Table 92. Thermo Fisher Scientific, Inc. Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 93. Thermo Fisher Scientific, Inc. Genetic Testing for Cancer Risk Product Offered
Table 94. Thermo Fisher Scientific, Inc. Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Thermo Fisher Scientific, Inc. Main Business
Table 96. Thermo Fisher Scientific, Inc. Latest Developments
Table 97. Twist Bioscience Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 98. Twist Bioscience Genetic Testing for Cancer Risk Product Offered
Table 99. Twist Bioscience Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Twist Bioscience Main Business
Table 101. Twist Bioscience Latest Developments
Table 102. Sophia Genetics Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 103. Sophia Genetics Genetic Testing for Cancer Risk Product Offered
Table 104. Sophia Genetics Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Sophia Genetics Main Business
Table 106. Sophia Genetics Latest Developments
Table 107. Fulgent Genetic, Inc. Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 108. Fulgent Genetic, Inc. Genetic Testing for Cancer Risk Product Offered
Table 109. Fulgent Genetic, Inc. Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. Fulgent Genetic, Inc. Main Business
Table 111. Fulgent Genetic, Inc. Latest Developments
Table 112. Medgenome Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 113. Medgenome Genetic Testing for Cancer Risk Product Offered
Table 114. Medgenome Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. Medgenome Main Business
Table 116. Medgenome Latest Developments
Table 117. CENTOGENE Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 118. CENTOGENE Genetic Testing for Cancer Risk Product Offered
Table 119. CENTOGENE Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. CENTOGENE Main Business
Table 121. CENTOGENE Latest Developments
Table 122. CeGaT Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 123. CeGaT Genetic Testing for Cancer Risk Product Offered
Table 124. CeGaT Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 125. CeGaT Main Business
Table 126. CeGaT Latest Developments
Table 127. LifeLabs Genetics Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 128. LifeLabs Genetics Genetic Testing for Cancer Risk Product Offered
Table 129. LifeLabs Genetics Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 130. LifeLabs Genetics Main Business
Table 131. LifeLabs Genetics Latest Developments
Table 132. Ambry Genetics Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 133. Ambry Genetics Genetic Testing for Cancer Risk Product Offered
Table 134. Ambry Genetics Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 135. Ambry Genetics Main Business
Table 136. Ambry Genetics Latest Developments
Table 137. BGI Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 138. BGI Genetic Testing for Cancer Risk Product Offered
Table 139. BGI Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 140. BGI Main Business
Table 141. BGI Latest Developments
Table 142. SOFIVA GENOMICS Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 143. SOFIVA GENOMICS Genetic Testing for Cancer Risk Product Offered
Table 144. SOFIVA GENOMICS Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 145. SOFIVA GENOMICS Main Business
Table 146. SOFIVA GENOMICS Latest Developments
Table 147. Yikon Medical Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 148. Yikon Medical Genetic Testing for Cancer Risk Product Offered
Table 149. Yikon Medical Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 150. Yikon Medical Main Business
Table 151. Yikon Medical Latest Developments
Table 1. Genetic Testing for Cancer Risk Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Genetic Testing for Cancer Risk Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Breast Cancer Risk Genetic Testing
Table 4. Major Players of Stomach Cancer Risk Gene Testing
Table 5. Major Players of Rectal Cancer Risk Genetic Testing
Table 6. Major Players of Others
Table 7. Genetic Testing for Cancer Risk Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Genetic Testing for Cancer Risk Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Genetic Testing for Cancer Risk Market Size Market Share by Type (2021-2026)
Table 10. Genetic Testing for Cancer Risk Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Genetic Testing for Cancer Risk Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Genetic Testing for Cancer Risk Market Size Market Share by Application (2021-2026)
Table 13. Global Genetic Testing for Cancer Risk Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Genetic Testing for Cancer Risk Revenue Market Share by Player (2021-2026)
Table 15. Genetic Testing for Cancer Risk Key Players Head office and Products Offered
Table 16. Genetic Testing for Cancer Risk Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Genetic Testing for Cancer Risk Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Genetic Testing for Cancer Risk Market Size Market Share by Region (2021-2026)
Table 21. Global Genetic Testing for Cancer Risk Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Genetic Testing for Cancer Risk Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Genetic Testing for Cancer Risk Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Genetic Testing for Cancer Risk Market Size Market Share by Country (2021-2026)
Table 25. Americas Genetic Testing for Cancer Risk Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Genetic Testing for Cancer Risk Market Size Market Share by Type (2021-2026)
Table 27. Americas Genetic Testing for Cancer Risk Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Genetic Testing for Cancer Risk Market Size Market Share by Application (2021-2026)
Table 29. APAC Genetic Testing for Cancer Risk Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Genetic Testing for Cancer Risk Market Size Market Share by Region (2021-2026)
Table 31. APAC Genetic Testing for Cancer Risk Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Genetic Testing for Cancer Risk Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Genetic Testing for Cancer Risk Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Genetic Testing for Cancer Risk Market Size Market Share by Country (2021-2026)
Table 35. Europe Genetic Testing for Cancer Risk Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Genetic Testing for Cancer Risk Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Genetic Testing for Cancer Risk Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Genetic Testing for Cancer Risk Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Genetic Testing for Cancer Risk Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Genetic Testing for Cancer Risk
Table 41. Key Market Challenges & Risks of Genetic Testing for Cancer Risk
Table 42. Key Industry Trends of Genetic Testing for Cancer Risk
Table 43. Global Genetic Testing for Cancer Risk Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Genetic Testing for Cancer Risk Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Genetic Testing for Cancer Risk Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Genetic Testing for Cancer Risk Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Myriad Genetics, Inc. Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 48. Myriad Genetics, Inc. Genetic Testing for Cancer Risk Product Offered
Table 49. Myriad Genetics, Inc. Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Myriad Genetics, Inc. Main Business
Table 51. Myriad Genetics, Inc. Latest Developments
Table 52. Invitae Corporation Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 53. Invitae Corporation Genetic Testing for Cancer Risk Product Offered
Table 54. Invitae Corporation Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Invitae Corporation Main Business
Table 56. Invitae Corporation Latest Developments
Table 57. Illumina, Inc. Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 58. Illumina, Inc. Genetic Testing for Cancer Risk Product Offered
Table 59. Illumina, Inc. Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Illumina, Inc. Main Business
Table 61. Illumina, Inc. Latest Developments
Table 62. Natera, Inc. Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 63. Natera, Inc. Genetic Testing for Cancer Risk Product Offered
Table 64. Natera, Inc. Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Natera, Inc. Main Business
Table 66. Natera, Inc. Latest Developments
Table 67. Laboratory Corporation of America Holdings Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 68. Laboratory Corporation of America Holdings Genetic Testing for Cancer Risk Product Offered
Table 69. Laboratory Corporation of America Holdings Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Laboratory Corporation of America Holdings Main Business
Table 71. Laboratory Corporation of America Holdings Latest Developments
Table 72. F. Hoffmann-La Roche Ltd Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 73. F. Hoffmann-La Roche Ltd Genetic Testing for Cancer Risk Product Offered
Table 74. F. Hoffmann-La Roche Ltd Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. F. Hoffmann-La Roche Ltd Main Business
Table 76. F. Hoffmann-La Roche Ltd Latest Developments
Table 77. Quest Diagnostics Incorporated Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 78. Quest Diagnostics Incorporated Genetic Testing for Cancer Risk Product Offered
Table 79. Quest Diagnostics Incorporated Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Quest Diagnostics Incorporated Main Business
Table 81. Quest Diagnostics Incorporated Latest Developments
Table 82. CooperSurgical, Inc. Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 83. CooperSurgical, Inc. Genetic Testing for Cancer Risk Product Offered
Table 84. CooperSurgical, Inc. Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. CooperSurgical, Inc. Main Business
Table 86. CooperSurgical, Inc. Latest Developments
Table 87. Agilent Technologies, Inc. Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 88. Agilent Technologies, Inc. Genetic Testing for Cancer Risk Product Offered
Table 89. Agilent Technologies, Inc. Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Agilent Technologies, Inc. Main Business
Table 91. Agilent Technologies, Inc. Latest Developments
Table 92. Thermo Fisher Scientific, Inc. Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 93. Thermo Fisher Scientific, Inc. Genetic Testing for Cancer Risk Product Offered
Table 94. Thermo Fisher Scientific, Inc. Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Thermo Fisher Scientific, Inc. Main Business
Table 96. Thermo Fisher Scientific, Inc. Latest Developments
Table 97. Twist Bioscience Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 98. Twist Bioscience Genetic Testing for Cancer Risk Product Offered
Table 99. Twist Bioscience Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Twist Bioscience Main Business
Table 101. Twist Bioscience Latest Developments
Table 102. Sophia Genetics Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 103. Sophia Genetics Genetic Testing for Cancer Risk Product Offered
Table 104. Sophia Genetics Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Sophia Genetics Main Business
Table 106. Sophia Genetics Latest Developments
Table 107. Fulgent Genetic, Inc. Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 108. Fulgent Genetic, Inc. Genetic Testing for Cancer Risk Product Offered
Table 109. Fulgent Genetic, Inc. Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. Fulgent Genetic, Inc. Main Business
Table 111. Fulgent Genetic, Inc. Latest Developments
Table 112. Medgenome Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 113. Medgenome Genetic Testing for Cancer Risk Product Offered
Table 114. Medgenome Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. Medgenome Main Business
Table 116. Medgenome Latest Developments
Table 117. CENTOGENE Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 118. CENTOGENE Genetic Testing for Cancer Risk Product Offered
Table 119. CENTOGENE Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. CENTOGENE Main Business
Table 121. CENTOGENE Latest Developments
Table 122. CeGaT Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 123. CeGaT Genetic Testing for Cancer Risk Product Offered
Table 124. CeGaT Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 125. CeGaT Main Business
Table 126. CeGaT Latest Developments
Table 127. LifeLabs Genetics Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 128. LifeLabs Genetics Genetic Testing for Cancer Risk Product Offered
Table 129. LifeLabs Genetics Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 130. LifeLabs Genetics Main Business
Table 131. LifeLabs Genetics Latest Developments
Table 132. Ambry Genetics Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 133. Ambry Genetics Genetic Testing for Cancer Risk Product Offered
Table 134. Ambry Genetics Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 135. Ambry Genetics Main Business
Table 136. Ambry Genetics Latest Developments
Table 137. BGI Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 138. BGI Genetic Testing for Cancer Risk Product Offered
Table 139. BGI Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 140. BGI Main Business
Table 141. BGI Latest Developments
Table 142. SOFIVA GENOMICS Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 143. SOFIVA GENOMICS Genetic Testing for Cancer Risk Product Offered
Table 144. SOFIVA GENOMICS Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 145. SOFIVA GENOMICS Main Business
Table 146. SOFIVA GENOMICS Latest Developments
Table 147. Yikon Medical Details, Company Type, Genetic Testing for Cancer Risk Area Served and Its Competitors
Table 148. Yikon Medical Genetic Testing for Cancer Risk Product Offered
Table 149. Yikon Medical Genetic Testing for Cancer Risk Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 150. Yikon Medical Main Business
Table 151. Yikon Medical Latest Developments
LIST OF FIGURES
Figure 1. Genetic Testing for Cancer Risk Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Genetic Testing for Cancer Risk Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Genetic Testing for Cancer Risk Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Genetic Testing for Cancer Risk Sales Market Share by Country/Region (2025)
Figure 8. Genetic Testing for Cancer Risk Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Genetic Testing for Cancer Risk Market Size Market Share by Type in 2025
Figure 10. Genetic Testing for Cancer Risk in Hospital
Figure 11. Global Genetic Testing for Cancer Risk Market: Hospital (2021-2026) & ($ millions)
Figure 12. Genetic Testing for Cancer Risk in Clinic
Figure 13. Global Genetic Testing for Cancer Risk Market: Clinic (2021-2026) & ($ millions)
Figure 14. Genetic Testing for Cancer Risk in Laboratory
Figure 15. Global Genetic Testing for Cancer Risk Market: Laboratory (2021-2026) & ($ millions)
Figure 16. Global Genetic Testing for Cancer Risk Market Size Market Share by Application in 2025
Figure 17. Global Genetic Testing for Cancer Risk Revenue Market Share by Player in 2025
Figure 18. Global Genetic Testing for Cancer Risk Market Size Market Share by Region (2021-2026)
Figure 19. Americas Genetic Testing for Cancer Risk Market Size 2021-2026 ($ millions)
Figure 20. APAC Genetic Testing for Cancer Risk Market Size 2021-2026 ($ millions)
Figure 21. Europe Genetic Testing for Cancer Risk Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Genetic Testing for Cancer Risk Market Size 2021-2026 ($ millions)
Figure 23. Americas Genetic Testing for Cancer Risk Value Market Share by Country in 2025
Figure 24. United States Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Genetic Testing for Cancer Risk Market Size Market Share by Region in 2025
Figure 29. APAC Genetic Testing for Cancer Risk Market Size Market Share by Type (2021-2026)
Figure 30. APAC Genetic Testing for Cancer Risk Market Size Market Share by Application (2021-2026)
Figure 31. China Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 35. India Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Genetic Testing for Cancer Risk Market Size Market Share by Country in 2025
Figure 38. Europe Genetic Testing for Cancer Risk Market Size Market Share by Type (2021-2026)
Figure 39. Europe Genetic Testing for Cancer Risk Market Size Market Share by Application (2021-2026)
Figure 40. Germany Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 41. France Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Genetic Testing for Cancer Risk Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Genetic Testing for Cancer Risk Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Genetic Testing for Cancer Risk Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 54. APAC Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 55. Europe Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 57. United States Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 58. Canada Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 59. Mexico Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 60. Brazil Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 61. China Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 62. Japan Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 63. Korea Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 65. India Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 66. Australia Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 67. Germany Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 68. France Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 69. UK Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 70. Italy Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 71. Russia Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 72. Egypt Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 73. South Africa Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 74. Israel Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 75. Turkey Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 76. Global Genetic Testing for Cancer Risk Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Genetic Testing for Cancer Risk Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 1. Genetic Testing for Cancer Risk Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Genetic Testing for Cancer Risk Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Genetic Testing for Cancer Risk Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Genetic Testing for Cancer Risk Sales Market Share by Country/Region (2025)
Figure 8. Genetic Testing for Cancer Risk Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Genetic Testing for Cancer Risk Market Size Market Share by Type in 2025
Figure 10. Genetic Testing for Cancer Risk in Hospital
Figure 11. Global Genetic Testing for Cancer Risk Market: Hospital (2021-2026) & ($ millions)
Figure 12. Genetic Testing for Cancer Risk in Clinic
Figure 13. Global Genetic Testing for Cancer Risk Market: Clinic (2021-2026) & ($ millions)
Figure 14. Genetic Testing for Cancer Risk in Laboratory
Figure 15. Global Genetic Testing for Cancer Risk Market: Laboratory (2021-2026) & ($ millions)
Figure 16. Global Genetic Testing for Cancer Risk Market Size Market Share by Application in 2025
Figure 17. Global Genetic Testing for Cancer Risk Revenue Market Share by Player in 2025
Figure 18. Global Genetic Testing for Cancer Risk Market Size Market Share by Region (2021-2026)
Figure 19. Americas Genetic Testing for Cancer Risk Market Size 2021-2026 ($ millions)
Figure 20. APAC Genetic Testing for Cancer Risk Market Size 2021-2026 ($ millions)
Figure 21. Europe Genetic Testing for Cancer Risk Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Genetic Testing for Cancer Risk Market Size 2021-2026 ($ millions)
Figure 23. Americas Genetic Testing for Cancer Risk Value Market Share by Country in 2025
Figure 24. United States Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Genetic Testing for Cancer Risk Market Size Market Share by Region in 2025
Figure 29. APAC Genetic Testing for Cancer Risk Market Size Market Share by Type (2021-2026)
Figure 30. APAC Genetic Testing for Cancer Risk Market Size Market Share by Application (2021-2026)
Figure 31. China Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 35. India Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Genetic Testing for Cancer Risk Market Size Market Share by Country in 2025
Figure 38. Europe Genetic Testing for Cancer Risk Market Size Market Share by Type (2021-2026)
Figure 39. Europe Genetic Testing for Cancer Risk Market Size Market Share by Application (2021-2026)
Figure 40. Germany Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 41. France Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Genetic Testing for Cancer Risk Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Genetic Testing for Cancer Risk Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Genetic Testing for Cancer Risk Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Genetic Testing for Cancer Risk Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 54. APAC Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 55. Europe Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 57. United States Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 58. Canada Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 59. Mexico Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 60. Brazil Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 61. China Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 62. Japan Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 63. Korea Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 65. India Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 66. Australia Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 67. Germany Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 68. France Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 69. UK Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 70. Italy Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 71. Russia Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 72. Egypt Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 73. South Africa Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 74. Israel Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 75. Turkey Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
Figure 76. Global Genetic Testing for Cancer Risk Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Genetic Testing for Cancer Risk Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Genetic Testing for Cancer Risk Market Size 2027-2032 ($ millions)
